Position in NVO
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$236,823
-$42,304 QoQ
Shares Held
4,940
-10.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#969
of 1,348 holders
Holding Since
Dec 2024
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FORTRESS PRIVATE LEDGER, LLC holds $9,976,276 across 8 Drug Manufacturers - General names. NVO ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,391 | $5,266,697 | |
| 2 | JNJ |
Johnson & Johnson
|
5,355 | $1,360,009 | |
| 3 | MRK |
Merck & Co., Inc.
|
8,543 | $1,097,775 | |
| 4 | ABBV |
AbbVie Inc.
|
3,713 | $934,339 | |
| 5 | AMGN |
Amgen Inc
|
1,720 | $622,846 | |
| 6 | PFE |
Pfizer Inc
|
10,076 | $242,630 | |
| 7 | NVO |
Novo Nordisk A S
This page
|
4,940 | $236,823 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,703 | $215,157 |
All Filings in NVO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $236,823 | 4,940 | Shares | Sole | 2026-08-07 | |
| 2025-12-31 | $279,127 | 5,486 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $232,503 | 4,190 | Shares | Sole | 2025-11-12 | |
| 2024-12-31 | $260,382 | 3,027 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||